Is IBXXF or ORCC a better dividend investment in 2026?

IBXXF currently yields 17857.14% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: IBXXF offers higher current income.

What is the dividend yield difference between IBXXF and ORCC?

IBXXF has a forward dividend yield of 17857.14% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 17847.35 percentage points.

Home › Compare › IBXXF vs ORCC

IBXXF vs ORCC: Dividend Comparison 2026

IBXXF yields 17857.14% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IBXXF wins by $17047106584171659264.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IBXXF

● Live price

17857.14%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$17047106584171659264.00M

Annual income

$16,861,361,028,467,424,000,000,000.00

Full IBXXF calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — IBXXF vs ORCC

📍 IBXXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IBXXF	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IBXXF + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IBXXF pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBXXF

Annual income on $10K today (after 15% tax)

$1,517,857.14/yr

After 10yr DRIP, annual income (after tax)

$14,332,156,874,197,310,000,000,000.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, IBXXF beats the other by $14,332,156,874,197,310,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBXXF + ORCC for your $10,000?

IBXXF: 50%ORCC: 50%

100% ORCC50/50100% IBXXF

Portfolio after 10yr

$8523553292085829632.00M

Annual income

$8,430,680,514,233,712,000,000,000.00/yr

Blended yield

98.91%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

IBXXF

No analyst data

Altman Z

-55.2

Piotroski

4/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBXXF buys

ORCC buys

Politician	Chamber	Ticker	Type	Amount	Date
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-23
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$250,001 - $500,000	2022-06-16
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-14
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$50,001 - $100,000	2022-06-13
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$50,001 - $100,000	2022-06-10
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-09
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-08
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$50,001 - $100,000	2022-06-03
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-05-24
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$100,001 - $250,000	2022-05-20

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIBXXFORCC

Forward yield	17857.14% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$17047106584171659264.00M ✓	$21.4K
Annual income after 10y	$16,861,361,028,467,424,000,000,000.00 ✓	$1.04
Total dividends collected	$17034838237245739008.00M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: IBXXF vs ORCC ($10,000, DRIP)

Year	IBXXF Portfolio	IBXXF Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$1,796,414	$1,785,714.29	$11,190	$489.61	+$1.79M → IBXXF
2	$301,724,280	$299,802,117.11	$12,229	$256.01	+$301.71M → IBXXF
3	$47,383,143,508	$47,060,298,527.98	$13,216	$130.74	+$47383.13M → IBXXF
4	$6,957,621,293,196	$6,906,921,329,642.40	$14,207	$66.02	+$6957621.28M → IBXXF
5	$955,290,364,037,133	$947,845,709,253,412.80	$15,234	$33.17	+$955290364.02M → IBXXF
6	$122,648,736,931,019,340	$121,626,576,241,499,600.00	$16,317	$16.62	+$122648736931.00M → IBXXF
7	$14,725,168,454,748,666,000	$14,593,934,306,232,474,000.00	$17,468	$8.32	+$14725168454748.65M → IBXXF
8	$1,653,272,868,532,626,000,000	$1,637,516,938,286,045,300,000.00	$18,695	$4.16	+$1653272868532626.25M → IBXXF
9	$173,593,977,293,677,440,000,000	$171,824,975,324,347,530,000,000.00	$20,006	$2.08	+$173593977293677440.00M → IBXXF
10	$17,047,106,584,171,660,000,000,000	$16,861,361,028,467,424,000,000,000.00	$21,407	$1.04	+$17047106584171659264.00M → IBXXF

IBXXF vs ORCC: Complete Analysis 2026

IBXXF — Stock

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.

Full IBXXF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this IBXXF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBXXF vs SCHD IBXXF vs JEPI IBXXF vs O IBXXF vs KO IBXXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.